In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India's Income Tax Department Tightens Noose Over Sanofi-Aventis' Shantha Biotech Deal; Claim Tax On Deal Made Over An "Indian" Asset

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Sanofi-Aventis is faced with more headwinds in India even as it tries to absorb the negative impact of the recent delisting of Shan 5 - its popular pentavalent vaccine - by the World Health Organization

You may also be interested in...



Sanofi Wins Crucial Tax Case In India Linked To Shantha Deal; Averts Charges Of Up To $170 Million

Sanofi’s deal for India’s Shantha Biotechnics was under the spotlight as India’s Income Tax department alleged that the deal was structured with an intention to avoid taxes. The decision may clear hurdles for other MNCs acquiring Indian companies.

Sanofi Wins Crucial Tax Case In India Linked To Shantha Deal; Averts Charges Of Up To $170 Million

Sanofi’s deal for India’s Shantha Biotechnics was under the spotlight as India’s Income Tax department alleged that the deal was structured with an intention to avoid taxes. The decision may clear hurdles for other MNCs acquiring Indian companies.

Will The Vodafone Win Against India’s Income Tax Department Benefit Sanofi In Shantha Deal?

India Supreme Court ruling in Vodafone case may set precedent for offshore acquisitions, but Sanofi-Shantha deal has key differences.

Related Content

UsernamePublicRestriction

Register

SC142523

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel